Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mu ...
Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mu ...
A study lasting 96 weeks to assess a combined treatment called Tezacaftor and Ivacaftor in children aged 6to 11 years who have Cystic Fibrosis A study lasting 96 weeks to assess a combined treatment called Tezacaftor and Ivacaftor in children ...
A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Tezacaftor in Combination With Ivacaftor in Subjects With Cystic Fibrosis Aged 6 Years and Older, Homozygous or Heterozygous for the F508del-CFTR Mutation A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment Wit ...